Rockefeller Capital Management L.P. Moleculin Biotech, Inc. Put Options Transaction History
Rockefeller Capital Management L.P.
- $36.3 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MBRX
# of Institutions
2Shares Held
3.35KCall Options Held
0Put Options Held
0About Moleculin Biotech, Inc.
- Ticker MBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,606,700
- Market Cap $48.6M
- Description
- Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....